Lazard adds senior New York healthcare advisors Koski and Lowe to strengthen advisory team

Lazard beefs up healthcare advisory team with senior New York hires

Strengthening advisory firepower in healthcare services

Lazard is adding John Koski and Rob Lowe as Managing Directors in its New York Healthcare Group, a move the firm says reinforces its ongoing investment in healthcare advisory capabilities. The appointments are part of a broader push to attract experienced bankers to Lazard’s entrepreneurial culture and global platform as clients face increasing strategic and financial complexity in the sector.

David Gluckman, Lazard’s Global Head of Healthcare, says the hires enhance the firm’s ability to deliver high‑impact advice to leadership teams, boards and investors navigating evolving healthcare policy, shifting payment models and rapid technological change. The firm frames the additions as a way to deepen client coverage across healthcare services and to improve execution on complex transactions that cross payor, provider and tech adjacencies.

Lazard positions the new appointments as complementary to its long‑term growth strategy in healthcare, emphasizing tailored financial solutions and advisory depth rather than broad product expansion. The firm highlights that strengthening senior bench‑strength in New York supports both cross‑border mandates and domestic deals, where specialized sector knowledge and trusted relationships increasingly influence outcomes.

Profiles of the new partners

Koski and Lowe join Lazard from Allen & Co., where each served as Managing Director advising payors, providers, distributors and companies at the intersection of healthcare and technology. Koski earlier trains as a Resident in Orthopedic Surgery and holds an MD from Yale School of Medicine and an MBA from Harvard Business School. Lowe previously worked as a Director in Healthcare at Citi’s Global Healthcare Investment Banking Group and holds an MBA from NYU Stern.

Strategic implications and sector backdrop

Lazard’s hires come as dealmakers in healthcare confront dynamic macroeconomic and capital markets conditions, regulatory uncertainty and accelerating digital transformation. By deepening senior coverage, Lazard seeks to capture mandates that require both clinical and capital markets acumen, positioning the firm to advise on consolidation, financing and strategic partnerships across the healthcare services landscape.